Clinical Trial: A Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of UBT251 Injection in Participants with Type 2 Diabetes Mellitus Inadequately Controlled with Diet and Exercise Alone (UNIGUIDE-1) (China)

China, Oct. 14 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of UBT251 Injection in Participants with Type 2 Diabetes Mellitus Inadequately Controlled with Diet and Exercise Alone (UNIGUIDE-1)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134319

Registration Time: 2026/10/13

Type: Interventional study

Primary Sponsor: The Second Xiangya Hospital of Central South University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341426

Published by HT Digital Content Services with permission f...